Vancomycin-resistant enterococci.
The enterococcus has emerged as one of the most important nosocomial pathogens: an organism with the ability to develop resistance to all available antibiotics. This article details the historic significance of the enterococcus and delineates the clinical presentations and therapeutic options for the clinician. In addition, recent guidelines from the Centers for Disease Control and Prevention are reviewed, and additional steps are suggested to prevent the spread of this scourge of the 1990s.
Thakor
K
K
Division of Infectious Diseases, Catholic Medical Center, Jamaica, New York, USA.
Glatt
A E
AE
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects*; D006801:Humans; D017053:Infection Control / Q000379:methods; D014640:Vancomycin / Q000494:pharmacology* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014640:Vancomycin